|
|
|
SPI USA, Inc, Baltimore, MD
December 5-6, 2006
The course will focus on the regulatory implications for regenerative medicine and the manufacturing processes for and quality control of regenerative products. In addition, this course will provide analysis of topics such as expansion of a variety of adult human stem cells and non stem-cell therapeutics. Case studies focusing on regulatory and manufacturing issues are also integrated into the seminar. This course is taught by SPI USA's team of experts, including Dr. Antonio Moreira, in collaboration with experts from Cognate Bioservices, Dr. Alan Smith and Dr. Aaron Heifetz.
|
|
|
|
|
|
Organized by:
|
|
SPI USA, Inc |
|
Invited Speakers:
|
|
Dr. Antonio Moreira, SPI USA Dr. Aaron Heifetz, Cognate BioServices Dr. Alan Smith, Cognate BioServices
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
Registration:
|
|
Please visit our website at www.usaspi.com
|
|
E-mail:
|
|
info@usaspi.com
|
|
|
|
|
|
|
|